Substandard and Falsified Medical Products Enforcement in Kenya

Content verification date: October 30, 2026

1. Key takeaways

• Kenya launched the Inter-sectoral Steering Committee (ISC) of the National Action Plan on Substandard and Falsified Medical Products on July 1, 2026, driven by the Ministry of Health. This is a landmark move that upgrades falsified product governance from single-agency PPB enforcement to cross-sector coordination.
• Enforcement intensity already shows measurable signals: public reporting states that intelligence-led operations have arrested more than 95 illegal operators, and that regulatory and disciplinary measures have been taken against 22 wholesale establishments suspected of supplying illegal outlets; earlier in the year, legacy unregistered products were removed from the official register. These figures come from public reporting and are treated by GRZAN as practical estimates.
• For companies, the real knock-on effect lies not with the counterfeiters themselves but with channel responsibility: establishment registration requires the official contact person to declare that procedures for the handling and disposal of substandard and falsified products are documented, and supply chain compliance is one of the ten LAR duties.
• The register clean-up means there is no longer any buffer for historical stock. Under Rule 3 of LN 100 of 2022, no person may import, manufacture or sell an unregistered health product or technology; once legacy unregistered products are removed from the register, they lose their shell of legality.
• The technical foundation of governance is being built in parallel: the national track and trace system goes live from August 3, 2026, first achieving batch-level traceability and transitioning to full serialisation on January 1, 2027. Falsified product governance and traceability transformation are the same project.

2. Legal basis

3. Expert insights

Insight 1: the cross-sector mechanism changes how evidence is gathered

GRZAN’s judgement: the ISC’s substantive change is not heavier penalties but stronger detection capability. PPB alone relied on the registration database and on-site inspections; once the cross-sector mechanism connects standards, customs, law enforcement and health data, identification points for falsified and substandard products move from the inspection site to import declaration and distribution. Grey buffers such as unregistered products in local channels or old certificates covering new models will surface quickly under cross-checked data. The removal of legacy unregistered products from the register earlier in the year was precisely the advance move of this logic.

Insight 2: the knock-on liability lands on compliant companies through supply chain duties

PPB’s requirements on companies were written into market entry long ago. The Guidelines for Registration of Medical Devices Establishments (PRA/LPP/GUD/072) require the official contact person to declare that procedures for the handling and disposal of substandard and falsified products are documented, and PPB conducts an on-site inspection; the ten LAR duties also include supply chain compliance. GRZAN notes that a compliant company’s duty goes beyond not selling falsified goods; it extends to acting when falsified products are found in the channel. Companies should write channel inspections, diversion screening and suspected falsified product reporting into executable procedures with records retained; otherwise the documented declaration loses support at inspection.

Insight 3: the register clean-up ends the illusion of grandfathered stock

Rule 3 of LN 100 of 2022 is drafted as a prohibition: health products or technologies not registered under the Rules may not be imported, manufactured or sold in Kenya by any person, and Rule 17 has already repealed the 1981 drug registration rules, so there is no transitional stock under the old regime. GRZAN therefore concludes that removing legacy unregistered products from the register is not an administrative tidy-up but a change of legality status. Products that previously had room for argument now fall within the Rule 3 prohibition and may enter the Rule 11 revocation route. Companies should use this moment for a full product line check confirming every model has a register entry.

Insight 4: falsified product governance and traceability transformation are two faces of one project

The ultimate technical answer to falsified products is serialisation. Kenya’s path is clear: the three national digital platforms go live from August 3, 2026, first achieving batch-level traceability and transitioning to full serialisation on January 1, 2027. GRZAN considers that companies should treat the traceability transformation not as a standalone IT project but as evidentiary capability for future falsified product checks: when suspected falsified goods appear, a company with a complete batch chain clears itself quickly, one without is trapped in an evidentiary dilemma. Compliance cost and risk cost converge here.

4. Practical recommendations

1. Run a full product line register check. GRZAN recommends checking each model against the PPB online register; any model without a corresponding entry should immediately enter a supplementary filing or exit plan.
2. Write the falsified product disposal procedure as an executable SOP. It should contain five steps: suspected product identification, sampling and testing, channel freeze, reporting to PPB, and delisting and destruction, with execution records retained.
3. Build a channel inspection and diversion screening mechanism. Conduct periodic spot checks at distribution endpoints and trigger an internal investigation whenever same-brand products without source documentation are found.
4. Verify the official contact person declaration in the establishment registration. Confirm that the declared procedures match the actual documents, so that declaration and documents do not diverge at inspection.
5. Align with batch-level traceability early. Complete the tidy-up of batch data fields and reporting interfaces within Q4 2026, leaving time before full serialisation on January 1, 2027.
6. Run a compliance self-check on advertising and promotional content. Review marketing materials against the advertising and promotion rules of LN 98 of 2022 to avoid being drawn into falsified promotion leads.

5. Verification checklist

• □ Can every model on sale be found as a corresponding entry in the PPB online register?
• □ Is the procedure for handling and disposing of substandard and falsified products documented, with the five execution steps?
• □ Are channel inspections and diversion screening scheduled annually, with records retained?
• □ Does the official contact person declaration in the establishment registration match the actual documents?
• □ Are the batch-level traceability data fields ready for connection to the national track and trace system?
• □ Have marketing materials been self-checked against the LN 98 of 2022 advertising rules?
• □ Are a responsible person and a reporting template designated for reporting suspected falsified products to PPB?

Regulatory information verified as of October 30, 2026.

In African markets, the GRZAN regulatory team focuses on Kenya, Nigeria, South Africa and Egypt and verifies every published regulatory conclusion against official gazettes, competent authority guidelines and public legal databases, with the verification date marked; figures, cycles and amounts not locatable in official sources are marked as practical estimates, not presumed.

GRZAN services cover market access strategy and risk classification; preparation and review of dossiers in CSDT, STED and CTD formats; selection and management of Local Authorized Representatives (LAR); QMS and GMP/GSDP compliance support; post-market vigilance, change management and recall response; import clearance and PVoC coordination; regulatory intelligence subscriptions and compliance ledgers.

For channel compliance, falsified product response and traceability readiness in Kenya, please contact the GRZAN regulatory team at info@grzanglobal.com.